Industry depth.
Engineering velocity.
Praverse stands at the junction of three decades of specialty pharmaceutical leadership and next-generation AI engineering — because the problems worth solving in healthcare don't yield to algorithms alone.
How a pharma veteran and an AI engineer
decided to build the same thing.
Pratham Shrivastav didn't set out to build technology for its own sake. He set out to find the problems most AI teams walk past — the kind that take decades of domain immersion to even see clearly. Vishal Jajodia had spent those decades. At SWATI, he shaped the development of specialty pharmaceutical portfolios, from Pentosan Polysulfate Sodium to women's health formulations, from GMP floors in Mumbai to panels in Rome. His conviction, formed across thirty years: intelligence in healthcare only earns trust when it's accountable to science. That conviction became Praverse's first principle.
Vishal Jajodia
Managing Director of SWATI Spentose
Three decades across the full arc of specialty pharma: from lab-grade formulation to global regulatory strategy. As MD of SWATI Spentose, Vishal leads a division built on one of the most enduring pharmaceutical legacies in India. He drove the development and commercialization of Pentosan Polysulfate Sodium (Intravesical Instillation), recognized with the IDMA-APTAR Innovation of the Year Award in 2022. His advisory to Praverse is grounded in lived experience: AI in healthcare doesn't work unless the people building it understand what clinicians actually need, and why the industry is structured the way it is.
- Managing Director, SWATI Spentose — part of the V-Group, established 1952, Mumbai
- IDMA-APTAR Innovation of the Year Award 2022 — Pentosan Polysulfate Sodium
- Founding Patron, GIBS — Global Interstitial Cystitis Bladder Pain Syndrome Society, est. 2016
- Keynote: PHARMEET 2013 · GREEN VOICE 2016 · ESSIC 2015, Rome Catholic University
- Domain focus: Women's Health, Urology, Specialty Formulation, GMP Strategy
Only global manufacturer of Pentosan Polysulfate Sodium outside the originator.
Largest pharmaceutical-grade melatonin manufacturer worldwide.
Three manufacturing units in Vapi, Gujarat. Commercial presence in 60+ countries.
Pratham Shrivastav
Founder & CEO · Praverse Tech
Pratham built Praverse around a single belief: AI systems for high-stakes, regulated domains must be engineered with the same rigor as the science they serve. Starting from published research in medical imaging and edge AI at IEEE and Scopus-indexed conferences, he leads the design of Praverse's intelligence stack: from MENNIE (ophthalmology) and HealthMate (clinical AI) to Pharma AI (regulatory intelligence) and the Foundry. Based in Vadodara, Gujarat. Building globally.
- IEEE Transactions on Medical Imaging — DME Detection, 98% accuracy
- Scopus-indexed: Netra Sakhi · Edge AI ophthalmic screening for low-resource settings
- Architect of MENNIE, HealthMate, Pharma AI, Photonics, Praverse Foundry
- Domain focus: Healthcare AI, Regulatory Intelligence, Edge AI, Assistive Robotics
Intelligence in healthcare earns trust only when it is accountable to science — and built by people who have been in the room long enough to know the difference.
This is the principle SWATI's domain depth and Praverse's engineering share.
Want to work with this team?
Reach out with a project, a partnership, or an idea worth exploring together.